Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
1.35T | 1.31T | 1.33T | 1.13T | 995.94B | 1.04T | Gross Profit |
479.91B | 439.48B | 466.65B | 418.45B | 352.38B | 362.00B | EBIT |
88.33B | 64.72B | 97.04B | 94.48B | 47.65B | 39.48B | EBITDA |
144.12B | 140.70B | 173.67B | 162.94B | 116.13B | 109.34B | Net Income Common Stockholders |
57.53B | 52.62B | 75.04B | 92.29B | 30.92B | 7.73B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
265.83B | 328.48B | 269.54B | 336.01B | 305.16B | 199.42B | Total Assets |
1.50T | 1.41T | 1.34T | 1.27T | 1.16T | 1.04T | Total Debt |
227.44B | 204.78B | 233.28B | 243.15B | 265.91B | 209.68B | Net Debt |
-38.38B | -123.70B | -34.10B | -92.09B | -38.10B | 13.42B | Total Liabilities |
666.55B | 601.96B | 614.10B | 600.68B | 608.37B | 534.87B | Stockholders Equity |
834.26B | 810.99B | 727.35B | 665.63B | 550.92B | 503.75B |
Cash Flow | Free Cash Flow | ||||
100.81B | 108.98B | 2.21B | 66.96B | 77.35B | 26.62B | Operating Cash Flow |
160.40B | 165.57B | 61.31B | 110.80B | 133.22B | 102.32B | Investing Cash Flow |
-148.69B | -58.98B | -61.60B | -44.08B | -57.45B | -76.13B | Financing Cash Flow |
-44.91B | -65.39B | -79.35B | -51.77B | 23.15B | -283.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
70 Neutral | $595.80B | 11.03 | 6.70% | 3.77% | 3.72% | 6.31% | |
61 Neutral | $11.28B | 10.16 | -6.88% | 2.97% | 7.41% | -8.93% | |
€962.56M | 14.14 | 10.97% | 2.87% | ― | ― | ||
$559.03M | 17.36 | 15.32% | 3.43% | ― | ― | ||
€980.84M | 5.04 | 30.22% | 1.60% | ― | ― | ||
75 Outperform | ¥102.28B | 14.06 | 2.80% | 8.95% | 4.60% | ||
73 Outperform | ¥86.17B | 20.09 | 5.18% | 0.03% | -23.96% |